Production (Stage)
Hoth Therapeutics, Inc.
HOTH
$1.19
-$0.11-8.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 42.64% | -13.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 45.85% | 11.77% | |||
| Operating Income | -45.85% | -11.77% | |||
| Income Before Tax | -45.86% | -11.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -45.86% | -11.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -45.86% | -11.77% | |||
| EBIT | -45.85% | -11.77% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 16.20% | -5.54% | |||
| Normalized Basic EPS | 16.20% | -5.54% | |||
| EPS Diluted | 16.20% | -5.54% | |||
| Normalized Diluted EPS | 16.20% | -5.54% | |||
| Average Basic Shares Outstanding | 74.06% | 5.92% | |||
| Average Diluted Shares Outstanding | 74.06% | 5.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||